Before 2033, will semaglutide be shown to improve lifespan, when prescribed to overweight people?
27
1kṀ43552033
83%
chance
1H
6H
1D
1W
1M
ALL
We'll check Google Scholar in 2033-Jan, and see how the long-term mortality data is looking for overweight people prescribed semaglutide. Must be significant at p<0.005. "Semaglutide" also refers to the brand names Ozempic, Wegovy and Rybelsus, etc.
Will semaglutide be shown to improve lifespan, when prescribed to overweight people?
This question is managed and resolved by Manifold.
Get 
1,000 to start trading!
1,000People are also trading
Related questions
Will 10 million Americans be on semaglutide (or yet-to-be-approved equally good or superior alternatives) by the end of 2030?
78% chance
Will Semaglutide cost less than $1000 per year before 2031?
82% chance
Will Semaglutide cost less than $2000 per year before 2031?
78% chance
Will Ozempic / semaglutide be FDA-approved for Alzheimer's before 2030?
62% chance
Will Semaglutide cost less than $1000 per year before 2030?
79% chance
Will medicare cover semaglutide (or an alternative) in 2030?
85% chance
Will compelling evidence be published before 2027 showing that semaglutide increases income?
38% chance
How much weight will I lose in 1 year on semaglutide?
Will Matt Kaeberlein start taking semaglutide/ozempic by 2030?
41% chance
Will one of the GLP agonist drugs (eg Semaglutude/Wegovy Tirzepatide/Mounjaro) have a black box warning by 2025
7% chance